AOSLMEDIUM SIGNALFINANCIAL10-K

AOSL demonstrated solid debt reduction and operational improvement with total debt declining 44% to $14.9M while operating cash flow grew 15% to $29.7M.

The substantial debt reduction combined with positive operating cash flow growth indicates strengthening financial discipline and cash management. However, the decline in cash reserves to $153.1M suggests the company may be using cash strategically for debt reduction or other corporate purposes, which warrants monitoring of liquidity management going forward.

Comparing 2025-08-28 vs 2024-08-23View on EDGAR →
FINANCIAL ANALYSIS

AOSL's financial profile improved meaningfully with total debt falling 44% to $14.9M and operating cash flow growing 15% to $29.7M, demonstrating stronger operational performance and debt management. The company's cash position declined modestly to $153.1M while total liabilities decreased 16% to $212.0M, reflecting an overall deleveraging trend. SG&A expenses increased 11% to $95.2M, suggesting continued investment in business operations, but the net financial picture shows a company strengthening its balance sheet through debt reduction and improved cash generation.

FINANCIAL STATEMENT CHANGES
Total Debt
Balance Sheet
-44.3%
$26.7M$14.9M

Debt reduced 44.3% — deleveraging strengthens balance sheet and reduces financial risk.

Total Liabilities
Balance Sheet
-16.4%
$253.4M$212.0M

Liabilities reduced 16.4% — deleveraging improves balance sheet strength and financial flexibility.

Operating Cash Flow
Cash Flow
+15.4%
$25.7M$29.7M

Operating cash flow grew 15.4% — strong conversion of earnings to cash, healthy business fundamentals.

Cash & Equivalents
Balance Sheet
-12.6%
$175.1M$153.1M

Cash decreased 12.6% — monitor burn rate and upcoming capital needs.

SG&A Expense
P&L
+11%
$85.7M$95.2M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

LANGUAGE CHANGES
NEW — 2025-08-28
PRIOR — 2024-08-23
ADDED
There were 30,013,611 shares of the registrant's common shares outstanding as of July 31, 2025.
Management's Discussion and Analysis of Financial Condition and Results of Operations 42 Item 7A.
Exhibits and Financial Statement Schedule 62 Signatures 107 (This page intentionally left blank.) PART I Item 1.
Our portfolio of power semiconductors includes approximately 2,800 products, and has grown with the introduction of over 100 new products in the fiscal year ended June 30, 2025, and over 100 and 60 new products in the fiscal years ended June 30, 2024 and 2023, respectively.
We have an extensive patent portfolio that consists of 949 issued patents and 64 pending patents in the United States as of June 30, 2025.
We also have a total of 961 foreign patents, which were based primarily on our research and development efforts through June 30, 2025.
We also developed new technologies and products designed to penetrate into markets beyond our MOSFET computing base, including the consumer, communications and industrial markets, Insulated Gate Bipolar Transistors, or IGBTs and integrated power modules for the home appliance market, as well as power integrated circuits ( ICs ) for personal computing ( PC ), advanced computing and gaming applications.
As of June 30, 2025, we owned approximately 39.2% of outstanding equity interest in a joint venture company (the JV Company ) that operates a power semiconductor packaging, testing and 12-inch wafer fabrication facility ( Fab , Chongqing Fab ) in the LiangJiang New Area of Chongqing, China, and the JV Company is an important supplier of wafers and assembly and test services to us.
On December 30, 2024, the JV Company signed an investment agreement with an investor, pursuant to which the investor agreed to invest RMB 500 million (or $68.5 million based on the currency exchange rate between RMB and 1 U.S.
Dollar on December 31, 2024) in the JV Company in exchange for a 7.09% interest.
REMOVED
There were 28,973,288 shares of the registrant's common shares outstanding as of July 31, 2024.
Management's Discussion and Analysis of Financial Condition and Results of Operations 43 Item 7A.
Exhibits and Financial Statement Schedules 66 Signatures 114 (This page intentionally left blank.) PART I Item 1.
Our portfolio of power semiconductors includes approximately 2,700 products, and has grown with the introduction of over 100 new products in the fiscal year ended June 30, 2024, and over 60 and 130 new products in the fiscal years ended June 30, 2023 and 2022, respectively.
We have an extensive patent portfolio that consists of 930 issued patents and 52 pending patents in the United States as of June 30, 2024.
We also have a total of 1,025 foreign patents, which were based primarily on our research and development efforts through June 30, 2024.
We also developed new technologies and products designed to penetrate into markets beyond our MOSFET computing base, including the consumer, communications and industrial markets, Insulated Gate Bipolar Transistors, or IGBTs for the home appliance market, as well as power ICs for next generation computing and gaming applications.
On March 29, 2016, we entered into a joint venture contract (the JV Agreement ) with two investment funds owned by the Municipality of Chongqing (the Chongqing Funds ), pursuant to which the Company and the Chongqing Funds formed a joint venture, (the JV Company ), for the purpose of constructing and operating a power semiconductor packaging, testing and 12-inch wafer fabrication facility in the Liangjiang New Area of Chongqing, China (the JV Transaction ).
As of December 1, 2021, we owned 50.9%, and the Chongqing Funds owned 49.1%, of the equity interest in the JV Company.
The Joint Venture was accounted under the provisions of the consolidation guidance since we had controlling financial interest until December 1, 1 2021.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →